2013
DOI: 10.1111/cge.12202
|View full text |Cite
|
Sign up to set email alerts
|

Whole‐genome copy number variation analysis in anophthalmia and microphthalmia

Abstract: Anophthalmia and microphthalmia (A/M) represent severe developmental ocular malformations. Currently, mutations in known genes explain less than 40% of A/M cases. We performed whole genome copy number variation analysis in sixty patients affected with isolated or syndromic A/M. Pathogenic deletions of 3q26 (SOX2) were identified in four independent patients with syndromic microphthalmia. Other variants of interest included regions with a known role in human disease (likely pathogenic) as well as novel rearrang… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
41
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(42 citation statements)
references
References 45 publications
0
41
0
Order By: Relevance
“…2013). The Database of Genomic Variants (http://projects.tcag.ca/variation/) was used as a control population along with 30 unaffected in‐house controls; a control population specifically matched to the patient's Trinidad and Tobago ancestry was not available.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…2013). The Database of Genomic Variants (http://projects.tcag.ca/variation/) was used as a control population along with 30 unaffected in‐house controls; a control population specifically matched to the patient's Trinidad and Tobago ancestry was not available.…”
Section: Methodsmentioning
confidence: 99%
“…Data were evaluated for mutations in 203 genes known to be involved in ocular development (Schilter et al. 2013) through the Geospiza GeneSifter Analysis program hosted through Perkin Elmer Bioinformatics. The entire exome was analyzed using the SNP & Variation Suite (SVS; Golden Helix, Bozeman, MT) as previously described (Deml et al.…”
Section: Methodsmentioning
confidence: 99%
“…Whereas mental (with often behavioral) impairment is almost always present, obesity, microcephaly, facial dysmorphism, skeletal and heart anomalies were observed with lower frequencies. Moreover, a single case with the typical dup3q29 presented with isolated anophthalmia , enlarging the clinical heterogeneity associated with the duplication 3q29 syndrome. In another patient with hemifacial microsomia (OMIM %164210) the 0.7 Mb duplication also affected region 3q29, but located proximal to the typical region .…”
Section: Phenotypic Features Of Patients With ‘Pure’ Duplication 3qmentioning
confidence: 96%
“…The female reported by Rosenberg et al also showed a paternally inherited dup3q29, associated with MI, facial dysmorphism and ataxia. Subsequently, Lisi et al , defined the dup3q29 syndrome and at least 25 patients have been described yet . However, several patients showed overlapping or smaller duplications or a dup3q29, that only bordered the common deleted region and these were excluded in a phenotype review provided by Fernández‐Jaén et al .…”
Section: Phenotypic Features Of Patients With ‘Pure’ Duplication 3qmentioning
confidence: 99%
“…Thus, such analysis benefits from additional biological insights through iSyTE . Indeed, several studies have successfully applied iSyTE in their investigations of eye and lens defects in human patients, namely for: 1) prioritization of novel candidate genes for pediatric cataract (Aldahmesh et al, 2012); 2) prioritization of promising candidates for anophthalmia and microphthalmia (Schilter et al, 2013); 3) linking ADAMTS18 in ocular syndrome in microcornea and myopia (Aldahmesh et al, 2013), 4) linking STX3 to congenital cataract (Chograni et al, 2014), and 5) identifying ASPH mutations that are associated with Traboulsi syndrome with ocular lens dislocation (Patel et al, 2014). Further, in 2012 iSyTE correctly predicted SIPA1l3 as a cataract-linked gene (Fig.…”
Section: Future Of Lens Research: Toward Lens Systems Biologymentioning
confidence: 99%